Sarah Sloot

520 total citations
15 papers, 388 citations indexed

About

Sarah Sloot is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Sloot has authored 15 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Sloot's work include Cutaneous Melanoma Detection and Management (7 papers), Melanoma and MAPK Pathways (5 papers) and Immunotherapy and Immune Responses (3 papers). Sarah Sloot is often cited by papers focused on Cutaneous Melanoma Detection and Management (7 papers), Melanoma and MAPK Pathways (5 papers) and Immunotherapy and Immune Responses (3 papers). Sarah Sloot collaborates with scholars based in Netherlands, United States and Germany. Sarah Sloot's co-authors include Jonathan S. Zager, Omar M. Rashid, Geoffrey T. Gibney, Keiran S.M. Smalley, Jeffrey S. Weber, Vernon K. Sondak, Peter Forsyth, Amod A. Sarnaik, James J. Mulé and Xiuhua Zhao and has published in prestigious journals such as Cancer, Cancer Discovery and Annals of Surgical Oncology.

In The Last Decade

Sarah Sloot

15 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Sloot Netherlands	10	201	159	130	57	48	15	388
Patrick Eulitt United States	8	154 0.8×	223 1.4×	73 0.6×	67 1.2×	35 0.7×	18	474
Flora Luo United States	7	100 0.5×	205 1.3×	103 0.8×	26 0.5×	42 0.9×	9	390
Na Chen China	13	119 0.6×	223 1.4×	40 0.3×	162 2.8×	51 1.1×	35	500
Stephen Schmidt United States	10	86 0.4×	163 1.0×	78 0.6×	30 0.5×	38 0.8×	16	347
Julian Musa Germany	8	113 0.6×	334 2.1×	108 0.8×	39 0.7×	17 0.4×	18	500
Yu-Ting Su Taiwan	8	110 0.5×	271 1.7×	47 0.4×	83 1.5×	111 2.3×	13	528
Ken Sin Lo Canada	12	280 1.4×	400 2.5×	43 0.3×	121 2.1×	43 0.9×	20	745
Nathalie Rousselet France	12	116 0.6×	273 1.7×	100 0.8×	23 0.4×	13 0.3×	15	467
Miyuki Nomura Japan	11	68 0.3×	237 1.5×	84 0.6×	41 0.7×	17 0.4×	20	384
Jillian P. Casey Ireland	11	58 0.3×	270 1.7×	34 0.3×	21 0.4×	39 0.8×	16	448

Countries citing papers authored by Sarah Sloot

Since Specialization

Citations

This map shows the geographic impact of Sarah Sloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Sloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Sloot more than expected).

Fields of papers citing papers by Sarah Sloot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Sloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Sloot. The network helps show where Sarah Sloot may publish in the future.

Co-authorship network of co-authors of Sarah Sloot

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Sloot. A scholar is included among the top collaborators of Sarah Sloot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Sloot. Sarah Sloot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sloot, Sarah, Y. Ann Chen, Xiuhua Zhao, et al.. (2017). Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies. Cancer. 124(2). 297–305. 73 indexed citations

Sloot, Sarah, Jonathan S. Zager, Ragini R. Kudchadkar, et al.. (2016). BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma. Melanoma Research. 26(1). 83–87. 20 indexed citations

Leclercq, Wouter K. G., Sarah Sloot, Bram J. Keulers, et al.. (2016). Challenging the knowledge base and skillset for providing surgical consent by orthopedic and plastic surgeons in the Netherlands: an identified area of improvement in patient safety. Patient Safety in Surgery. 10(1). 21–21. 5 indexed citations

Sloot, Sarah, Omar M. Rashid, Amod A. Sarnaik, & Jonathan S. Zager. (2016). Developments in Intralesional Therapy for Metastatic Melanoma. Cancer Causes & Control. 23(1). 12–20. 4 indexed citations

Sloot, Sarah, et al.. (2016). Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature. Cancer Treatment Reviews. 45. 120–128. 5 indexed citations

Sloot, Sarah, Omar M. Rashid, Amod A. Sarnaik, & Jonathan S. Zager. (2016). Developments in Intralesional Therapy for Metastatic Melanoma. Cancer Control. 23(1). 12–20. 32 indexed citations

Bastiaannet, Esther, et al.. (2015). Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed?. Annals of Surgical Oncology. 22(9). 2978–2987. 26 indexed citations

Paraiso, Kim H.T., Meghna Das Thakur, Bin Fang, et al.. (2014). Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype. Cancer Discovery. 5(3). 264–273. 85 indexed citations

Leclercq, Wouter K. G., Sarah Sloot, Bram J. Keulers, J. Legemaate, & Marc R. Scheltinga. (2014). [Preoperative medical record-keeping can be improved: new informed consent form assists both physicians and patients].. PubMed. 158. A7109–A7109. 1 indexed citations

10.

Rashid, Omar M., Sarah Sloot, & Jonathan S. Zager. (2014). Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion. Expert Opinion on Drug Metabolism & Toxicology. 10(10). 1355–1364. 15 indexed citations

11.

Sloot, Sarah, et al.. (2014). Bilateral catheter-directed thrombolysis in a patient with deep venous thrombosis caused by a hypoplastic inferior vena cava. Phlebology The Journal of Venous Disease. 30(4). 293–295. 4 indexed citations

12.

Sloot, Sarah, Jason W Boland, John A. Snowden, et al.. (2014). Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Supportive Care in Cancer. 23(3). 671–678. 31 indexed citations

13.

Sloot, Sarah, Omar M. Rashid, & Jonathan S. Zager. (2014). Intralesional therapy for metastatic melanoma. Expert Opinion on Pharmacotherapy. 15(18). 2629–2639. 15 indexed citations

14.

Ahmed, Kamran A., J. Freilich, Sarah Sloot, et al.. (2014). LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases. Journal of Neuro-Oncology. 122(1). 121–126. 48 indexed citations

15.

Roermund, Joep G.H. van, Dieuwertje E. Kok, Mark F. Wildhagen, et al.. (2009). Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy. British Journal of Urology. 104(3). 321–325. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact